![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/3/2020 15:52 | 20-30p waitFer theDump. ItHas ahistory ofDelays. Historical pump&Dump | ![]() andymunchkin | |
30/3/2020 15:52 | Hi Ant, Agreed. 1. I believe that we’ve seen confirmation the trial has started - 1 down, 2 to go 2. Date TBC for results 3. Give it to a formula 1 team to rush it into production:) Pleased everyone is on good spirits today - keep it up | ![]() makendon | |
30/3/2020 15:51 | Ten million shares traded! | ![]() nobbygnome | |
30/3/2020 15:49 | >> hms Drug development is not empirical in that way as I have learnt from bitter experience over the years. There are many things which can cause a drug to fail which is why you do placebo controlled trials. From what I know I put the chance of success at 75:25 but of course that is a guesstimate. The bottom line is there are no certainties in drug development. No investment advice intended and DYOR.... | ![]() nobbygnome | |
30/3/2020 15:47 | Makendon X3 important announcements to follow and assuming successful outcomes ( I can see no reason why not ): Start of Trial Results of Trial Production Data....leading to sales date analysis | ![]() ant15 | |
30/3/2020 15:39 | Hi Nobby, any views on my 13.33? Thanks! | ![]() hms_trader | |
30/3/2020 15:31 | From the RNS about trial locations: Synairgen's Phase II trial in COVID-19 patients (SG016) will be a double-blind, placebo-controlled trial. Initially, the pilot phase of the study will involve 100 COVID-19 patients, will take place across a number of NHS trusts and has been adopted by the NIHR Respiratory Translational Research Collaboration which is comprised of leading centres in respiratory medicine in the UK whose internationally recognised experts are working together to accelerate development and discovery for COVID-19. | ![]() jev1 | |
30/3/2020 15:23 | Well I got it! Let's hope 60 becomes support - (see back to 2008) Then there is a blip at 70 and if that goes 100 looks on the cards. | ![]() toffeeman | |
30/3/2020 15:20 | Drug developers and inoculators Moving from diagnostics to treatment, multiple junior biotechs are moving forward with their own potential therapies that could alleviate the symptoms of coronavirus. Synairgen PLC (LON:SNG) has recently raised £14mln to fund the trial of its interferon-beta treatment in coronavirus patients. The drug, SNG001, is an inhaled formulation of interferon-beta-1a and is currently being developed to treat people with chronic obstructive pulmonary disease (COPD) that also have respiratory viral infections such as coronavirus. Hopes that the treatment will protect COPD sufferers from lung damage resulting from a coronavirus infection have driven the stock 214% higher to 55p over the last month. | ![]() makendon | |
30/3/2020 15:18 | No see my posts earlier this morning. International trials, just not being led by University of Southampton. | ![]() talk2dubya | |
30/3/2020 15:17 | MAKENDON....You know what they say... the best trade isn't usually an easy trade'. | ![]() hazl | |
30/3/2020 15:14 | Go back to oil stocks your get burnt munchkin | ![]() bobaxe1 | |
30/3/2020 15:12 | talk2dubya 30 Mar '20 - 15:02 - 1454 of 1460 Not the only trial using SNG-001 IMO. Talk2 -- I believe you are correct. Nottingham hospital doing a trial ? | ![]() westmoreland lad | |
30/3/2020 15:09 | ThisIs goingTo endUp in tears,betterSell while uCan. Tidy2 cntsR pumpingTis | ![]() andymunchkin | |
30/3/2020 15:07 | Good stuff, ow let's stay in the 60s and beyond. Wish I'd bought more on the drop after the raise RNS. Oh well will make do with what I have. | ![]() tickboo | |
30/3/2020 15:06 | 61p to sell now moving up. | ![]() wardy333 | |
30/3/2020 15:04 | Thank the lord, that’s me back at break even :) Enjoying the ride | ![]() makendon | |
30/3/2020 15:04 | That's a bit rich. You've flooded that board too. I'm invested in both and both look good to me. I imagine both will be a fair whack higher in the coming weeks and will enjoy the ride | ![]() tickboo | |
30/3/2020 15:03 | It is definitely going for gold | ![]() dave444 | |
30/3/2020 15:03 | Flipping heck!! | ![]() 801710245 | |
30/3/2020 15:02 | Not the only trial using SNG-001 IMO. | ![]() talk2dubya | |
30/3/2020 15:01 | Enjoy the fundraising | ![]() dave444 | |
30/3/2020 15:00 | Double post | ![]() nobbygnome | |
30/3/2020 15:00 | >> Lith Dear oh dear, sorry but that post is nonsense. They will not dose all the patients on the first day. There will be a slow build of patients with more recruited towards the end. So they might get the first result next Monday but it will be blinded and no-one will know if the patient was on placebo or drug! | ![]() nobbygnome | |
30/3/2020 15:00 | Excellent post LH, the market certainly seems to point to that being the case... | ![]() 74tom |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions